Defective and Dangerous Medication Lawsuits

Drug manufacturers have a duty to make sure that medications they sell are not unreasonably dangerous and contain sufficient warnings about dangerous side effects so that physicians and patients can evaluate the risks and benefits before taking the medication. In many cases pharmaceutical companies fail to take simple steps to protect consumers when they place profits before people’s safety.

Side effect lawsuits are investigated nationwide for users of the following medications who suffered an injury. To review a potential case for yourself, a friend or family member, request a free consultation and claim evaluation.

  • Abilify

    Abilify (aripiprazole) was approved by the FDA in 2002, for the treatment of a number of psychological problems, including schizophrenia, bipolar disorder, depression and autism in adults and children. Many users of Abilify have reported side effects such as gambling addictions, unusual sexual behavior, compulsive shopping and other impulsive activities. Abilify can also can an increased risk of diabetes in children.


  • Actemra

    Actemra (tocilizumab) is a blockbuster rheumatoid arthritis drug introduced by Roche in January 2010. Similar drugs contained strong warnings about the cardiovascular risks and other health problems, Actemra warnings did not indicate that users may experience a heart attack, stroke, heart failure, lung disease, pancreatitis or other serious side effects. As a result, many doctors and patients were falsely led to believe that Actemra was safer, which does not appear to be the case.


  • Antibiotics (Avelox / Levaquin / Cipro)

    Side effects of Levaquin, Avelox, Cipro and other fluoroquinolone antibiotics have been linked to a risk of aortic dissection, aortic aneurysms and permanent nerve damage, known as peripheral neuropathy.

  • Depakokte

    Depakote, which was approved in 1983, is used to treat epilepsy and, in some cases, depression. However, use Depakote during pregnancy may result in severe birth defects including autism, malformed limbs, spina bifida, cleft-palate and other severe health problems.

  • Diabetes Drugs (Byetta / Victoza / Januvia / Janumet)

    Byetta, Victoza, Januvia and Janumet are all type II diabetes medications that are part of a class of drugs known as incretin mimetics. Use of the drugs has been linked to a risk of pancreatitis, which may cause some users to develop pancreatic cancer.

  • Diflucan

    Diflucan (fluconazole) is the first of a relatively new subclass of anti-fungal medications, which is used for treatment of certain kinds of yeast infections and meningitis caused by a type of fungus. Diflucan side effects have been linked to an increased risk of serious and potentially life-threatening health problems and birth defects for babies when high doses of the medication are used during pregnancy.

  • Effexor

    Effexor (venlafaxine) is an antidepressant manufactured and sold by Pfizer, and is one of the most widely prescribed SSRIs. Studies show that women who have taken Effexor while pregnant can result in heart defects and other malformations in their child.

  • Essure

    Essure is marketed for long-term protection against pregnancy. However, thousands of women have reported suffering severe and debilitating side effects including infections, ectopic pregnancy and other internal injuries.

  • Heartburn Drugs (Nexium, Prilosec, Protonix, Other PPIs)

    Proton Pump Inhibitors (PPI) are a class of drugs used for treatment of acid reflux, heartburn, ulcers and other gastroinstestinal problems. Members of this class include popular medications like Nexium, Prilosec, Prevacid, Protonix, AcipHex, Dexilant, Vimovo, Zegerid and others.

  • Invokana

    Invokana (canagliflozin) was introduced by Johnson & Johnson in March 2013, as a powerful new type II diabetes medication. However, it has been linked to potential life-threatening risks including kidney failure, diabetic ketoacidosis and other kidney problems.

  • Mirena

    The Mirena IUD (Intra-Uterine Device) was introduced by Bayer and approved by the FDA in 2000 as a long-acting form of birth control that is implanted into the uterus. However, many women have suffered severe complications where Mirena IUD perforated the uterus and migrated to other areas of the body.

  • Nuvaring

    ]The NuvaRing is a small and flexible birth control ring, which is designed to be inserted into the vagina once a month. Side effects of NuvaRing may cause women to face an increased risk blood clots when compared to use of some older birth control pills.

  • Risperdal

    Risperdal (risperidone) is an atypical antipsychotic, which has been prescribed to children for bi-polar disorders, autism, irritability, aggression and behavior disorders. Risperdal has a serious side effect in boys that causes male breast growth, also known as Gynecomastia. Johnson & Johnson failed to warn about these serious side effects leaving many children with abnormal breast growth requiring expensive plastic surgery to correct.

  • Tasigna

    Tasigna (nilotinib) was introduced by Novartis in 2007, for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) among newly diagnosed adults. Evidence suggests Tasigna may cause atherosclerosis, increasing the risks of strokes, heart attacks and the need for amputations in patients using the drug.

  • Taxotere

    Taxotere (docetaxel) was introduced by Sanofi-Aventis in 1996 for treatment of metastatic or locally advanced breast cancer along with other chemotherapy drugs. Although chemotherapy is known to cause hair loss, Taxotere warnings fail to indicate that these hair loss problems are often permanent and can lead to Alopecia, where the body’s immune system attacks and kills any new hair follicles, preventing any new hair growth.

  • Testosterone Drugs (AndroGel, Testim, Axiron)

    Recent studies have suggested that certain users of testosterone replacement therapy may face an increased risk of heart attacks, stroke, blood clots and sudden death. Cases are reviewed for users of prescription “Low T” drugs, including AndroGel, AndroDerm, Textim, Axiron and others.

  • Topamax

    Topamax, known generically as topiramate, was first introduced in 1979 by McNeil Pharmaceutical, which was approved for treatment of epilepsy and migraine headaches, but are also often prescribed off-label to treat bipolar disorder. Topamax side effects may increase the risk of an unborn child developing an oral cleft or other major birth defects for mothers who has used Topamax during pregnancy.

  • Uloric

    Uloric (febuxostat) was introduced by Takeda Pharmaceuticals in 2009, and aggressively marketed for treatment of gout. In February 2019, the FDA required a new “boxed” warning about the increased risk of cardiovascular events and death on Uloric when compared to use of the other gout drugs.

  • Valsartan

    In July 2018, the FDA announced a nationwide recall was issued for certain versions of generic valsartan and valsartan HCTZ, (a hypertension drug) after it was discovered that they may be contaminated with an impurity known as N-nitrosodimethylamine (NDMA), which is a known human carcinogen. Cases are being reviewed for those affected.

  • Viagra/Cialis

    Viagra (sildenafil citrate) is one of the most widely recognized brand name drugs, used for men experiencing erectile dysfunction. Studies have shown men taking Viagra may face an increased risk of developing melanoma skin cancer.

  • Xarelto

    Xarelto (rivaroxoaban) was introduced in 2011, as an anticoagulant to reduce the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE) and other blood clot injuries. However, side effects of the medication have been linked to reports of uncontrollable bleeding and wrongful death.

  • Xeljanz

    Xeljanz (tofacitinib) is the first member of a new class of drugs, which has been approved for treatment of rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. However, it now appears that the drug maker failed to adequately warn about the increased the risk of dangerous and potentially life-threatening blood clots in the lungs and other injuries.

  • Zoloft

    Zoloft, a commonly prescribed anti-depressant has been shown to increase risk of birth defects or malformations in unborn children for mothers who used the SSRI antidepressant Zoloft during pregnancy.

  • Zofran

    Zofran (ondansetron) is an anti-nausea and vomiting medication that has been prescribed off-label for morning sickness in pregnant women. the drug maker has placed their desire for profits before consumer safety by reckless promoting and encouraging the off-label use of Zofran for morning sickness, while withholding information about the risk of birth defects.

  • Zostavax

    Zostavax is a live varicella zoster virus (VZV) vaccine, which was the first available injection for prevention of shingles among older adults. Although the shingles vaccine was marketed as safe and effective, increasing evidence suggests that side effects of Zostavax may actual cause the infection it is designed to prevent.

Previously Investigated Drugs:

The drug injury lawyers at Saiontz & Kirk, P.A. previously reviewed and investigated potential claims for users of the following medications. New cases are no longer being accepted for users of these medications at this time, but the following pages are available for informational purposes.